February 2011
As more specialty pharmaceuticals products continue to come to the market, the manufacturer's goal should be to understand what will impact payer coverage.
Advertisement
Advertisement
Trending on Pharmacy Times
1
CVS Health Expands GLP-1 Access With $29 Visits, Lilly Deal
2
FDA Approves mFlusiva, the First mRNA-Based Influenza Vaccine
3
The Side Door We Could Close: A Pharmacy Perspective on Menopause, Access, and the Leadership Pipeline
4
Real-World Semaglutide Use Linked to Lower Liver Stiffness, With Benefits Beyond Weight Loss
5